Additional bibliography of references

Updated May 27, 2023

+ Share This Article

Select Broadcast Media Reports on Gardasil Vaccine

Aug. 19, 2009. “Gardasil Researcher Speaks Out,” a report by Sharyl Attkisson, CBS-TV.
Nov. 11, 2008. “One Mother’s Story & Bigger Questions About the U.S. Vaccine Safety System,” an investigate report by Jane Miller, WBAL-TV 11 (Baltimore).

Selected Print Media Reports

The Pharmaceutical Journal Trials of HPV vaccine may have overestimated its efficacy, study finds Royal Pharmaceutical Society Feb. 4, 2020
Cluskey P. Sharp drop in number of Dutch teenage girls getting HPV vaccination. The Irish Times. Jun. 27, 2018.
Sagonowsky E. Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines. FiercePharma. Jun. 12, 2018
Llamas M. Florida Mom Says HPV Vaccine Ruined Daughter’s Life. Drugwatch. May 15, 2018.
Pulla, P. Understanding the HPV vaccine’s risk. The Hindu. Feb. 5, 2018.
Joelving F. What the Gardasil Testing May Have Missed. Slate. Dec. 17, 2017.
Cullen P. Almost 650 girls needed medical intervention after HPV vaccine. The Irish Times. Sep. 12, 2017.
Guevara C. Class Action Lawsuit Against HPV Vaccine Filed in Colombia. Medscape. Aug. 7, 2017.
Aoki, M. Suit opens in Tokyo court over cervical cancer vaccine side effects. The Japan Times Feb. 13, 2017
Chustecka Z. Class Action Lawsuit Against HPV Vaccine Filed in Japan. Medscape. Jul. 27, 2016.
Chustecka Z. Complaint Filed Over EMA's Handling of HPV Vaccine Safety Issues. Medscape. Jul. 5, 2016
Chustecka Z. Case Reports of 'Syndrome' Appearing After HPV Vaccination. Medscape. Sep. 18, 2015
Gallagher P. Thousands Of Teenage Girls Report Feeling Seriously Ill After Routine School Cancer Vaccination. The Independent. May 31, 2015.
Dennis B. Five pressing health priorities in 2014. Washington Post. Dec. 28, 2013.
Sanofi sued in France over Gardasil vaccine. Reuters. Nov. 24, 2013.
Baklinski T. Japan Withdraws Support of Controversial HPV Vaccine Over Safety Concerns. Lifesite News. Oct. 16, 2013.
Mulcahy, N. Japan Withdraws HPV Vaccine Recommendation for Girls. Medscape. Jun. 25, 2013.
Castillo M. Side effect fears stop parents from getting HPV vaccine for daughters. CBS News. Mar 18, 2013.
Gonthier V. Family Sues After Teen Dies Following HPV Vaccination. Toronto Sun. Jan. 31, 2012.
Green G. Gardasil: Krystal’s Story. Women Hurt by Medicine. May 14, 2010.
Scoop Independent News (NZ). Vaccine Roll-Out Is Wrong Without Honest Advice. Feb. 28, 2009.
Hart, B. “Gardasil Vaccine for boys?” Seattle Post Intelligencer . Jan. 16, 2009.
“FDA Again Says No to Expanded Gardasil Use”. Wall Street Journal. Jan. 9, 2009.
Edelman S. Fed’s Warning Shot. New York Post. Jul. 6, 2008.
“My Girl Died as ‘Guinea Pig’ for Gardasil” New York Post. Jul. 20, 2008.
“Is HPV Vaccine To Blame for Teen’s Paralysis?” US News & World Report. Jul. 2, 2008.
“Judicial Watch Uncovers New FDA Records Detailing Ten New Deaths & 140 “Serious” Adverse Events Related to Gardasil.” Judicial Watch. June 30, 2008.
“Anti-Vaccine Activists vs. Gardasil”. Time Magazine. Jun. 19, 2008.
UCSF Doctors Warn on Wide Use of Cervical Cancer Vaccine. San Francisco Chronicle. May 10, 2007.
“Merck posts 12% profit rise, affirms 2007 forecast”. Market Watch. Apr. 19, 2007.
“VA set to Mandate Gardasil”. Boston Globe. Mar. 3, 2007.
Drugmaker Assists In Pushing for Mandate For HPV. Washington Post. Feb. 11, 2007. .
Letter to the Editor from Barbara Loe Fisher, “Risk, Racism and the HPV Vaccine”. Washington Post. Feb. 1, 2007.
“Force Is Not the Only Way to administer a Vaccine” by Courtland Milloy. Washington Post. Jan. 24, 2007.
D.C. Bill Would Mandate Vaccine. Washington Post. Jan. 10, 2007.
“A New Vaccine for Girls, But Should It Be Compulsory?” by Roni Rabin. New York Times. Jul. 18, 2006.

Selected Medical Literature Articles

Shiller JT, Lowy DR. Papillomavirus-Like Particle Vaccines. J Natl Cancer Inst. Monogr 2000; 28: 50-54.
Baylor NW, Egan W, Richman P. Aluminum salts in vaccines – US perspective. Vaccine May 31, 2002; 20Supple 3: 518-523.
Burd EM. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev 2003; 16(1): 1-17.
Haug CJ. Human Papillomavirus Vaccine: Reason for Caution. NEJM 2008; 359: 861-862.
Slade BA, Leidel L, Vellozzi C, Woo EJ et al. Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine. JAMA 2009; 302(7): 750-757.
Sutton I, Lahoria R et al. CNS Demyelination and Quadrivalent Vaccination. Mult Scler 2009; 15: 116-119.
Rothman SM, Rothman DJ. Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism. JAMA 2009; 302(7): 781-786.
Haug C. The Risks and Benefits of HPV Vaccination. JAMA 2009; 302(7): 795-796.
Alvarex-Sonia MJ, Hernandez-Gonzalez A et al. Demyelinating Disease and Vaccination of the Human Papillomavirus. Rev Neurol 2011; 52(8): 472-476.
Souayah N, Michas-Martin PA. Guillain Barre syndrome after Gardasil vaccination: data from Vaccine Adverse Events Reporting System 2006-2009. Vaccine 2011; 29(5) 886-889.
Klein NP, Hansen J et al. Safety of Quadrivalent Human Papillomavirus Vaccine Administered Routinely to Females. JAMA Pediatrics 2012; 166(12): 1140-1148.
Soldevilla HF, Brones SFR, Navarra SV. Systemic lupus erythematosus following HPV immunization or infection?. Lupus Feb. 2012; 21: 158-161.
Van Bogaert LJ. Are the currently existing anti-human papillomavirus vaccines appropriate for the developing world? AMHSR 2013; 3(3): 306-312.
Pons-Salort M, Tiebault ACM et al. HPV genotype replacement: too early to tell. The Lancet Infectious Diseases 2013; 13(12): 1012.
Arnheim-Dahlstrom L, Pasternak B et al. Autoimmune, neurologic, and venous thromboembolic adverse events after immunization of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study. BMJ 2013; 347
Mariani L, Venuti A. HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future. Journal of Translational Medicine 2010; 8:105.
Colafranceso S Perricone C et al. Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Facet of Autoimmune/Inflammatory Syndrome Induced by Adjuvants. American Journal of Reproductive Immunology 2013.
Binagwaho A, Wagner CM et al. Achieving a high coverage in Rwanda’s national human papillomavirus programme. Bulletin of the World Health Organization 2012; 90: 623-28.
Batson A, Meheus F, Brooke S. Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine Aug 31, 2006;24 Suppl 3:S3/219-25.
Gupta S., Kerkar R A., et al. Is human papillomavirus vaccination likely to be a useful strategy in India? South Asian J Cancer. 2013 Oct-Dec; 2(4): 193–197.
Tomljenovic, L., Colafrancesco, S., et al. Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the “Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants” Case Report and Literature Review. J Investig Med High Impact Case Rep. 2014 Jan-Mar; 2(1): 2324709614527812.
Little, D.T., Ward, H.R., Adolescent Premature Ovarian Insufficiency Following Human Papillomavirus Vaccination: A Case Series Seen in General Practice. J Investig Med High Impact Case Rep. 2014 Oct 28;2(4):2324709614556129.
Palmieri B, Piddighe D et al. Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature. Immunol Res 2017; 65(1): 106-116.
Chandler RE, Juhlin K et al. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase. Drug Safety 2017; 40_ 81-90.
Chandler, R.E. Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient? Drug Saf. 2017; 40(12): 1167–1170.
Cervantes LJ, Doan AH. Discrepancies in the evaluation of the safety of the human papillomavirus vaccine. Mem Inst Oswaldo Cruz 2018; 113(8).
Jørgensen L., Gøtzsche P.C., et al Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review. Syst Rev. 2018; 7: 8.
Rees CP, Brhlikova P, Pollock AM. Will HPV vaccination prevent cervical cancer? J R Soc Med. Jan 21, 2020:141076819899308.

National Institutes of Health (NIH)

Biological Therapies for Cancer
Cancer Stat Fact Sheets (National Cancer Institute)

American Cancer Society

IMPORTANT NOTE: NVIC encourages you to become fully informed about HPV and the HPV vaccine by reading all sections in the Table of Contents , which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.